Prosecution Insights
Last updated: August 18, 2026

Examiner: KENYON, JOHN S

Tech Center 1600 • Art Units: 1622 1625 1629

This examiner grants 80% of resolved cases

Performance Statistics

80.2%
Allow Rate
+20.2% vs TC avg
991
Total Applications
+17.5%
Interview Lift
853
Avg Prosecution Days
Based on 945 resolved cases, 2023–2026

Rejection Statute Breakdown

4.1%
§101 Eligibility
22.0%
§102 Novelty
16.3%
§103 Obviousness
42.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18305609 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING APPARATUS Non-Final OA SEMICONDUCTOR ENERGY LABORATORY CO., LTD.
17934277 Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function Genes Non-Final OA Regeneron Pharmaceuticals, Inc.
18560179 LIVER X RECEPTOR MODULATORS Non-Final OA TRUSTEES OF DARTMOUTH COLLEGE
18113369 DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS Non-Final OA National University Corporation Tokyo Medical and Dental University
18194867 FORMULATIONS AND METHODS FOR IMPROVING AVIAN HEALTH Non-Final OA CORNELL UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month